One important metric to look for in a stock is an 80 or higher Relative Strength Rating. GRAIL just hit that mark, with a jump from 71 to 83 Wednesday.
This exclusive rating from Investor's Business Daily identifies price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the best stocks often have an 80 or higher RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
GRAIL is not currently offering a proper buying opportunity. See if the stock goes on to form a sound pattern that could spark a new run.
The company showed 0% earnings growth in its most recent report. Revenue gains came in at 38%.
The company earns the No. 21 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Guardant Health and Option Care Health are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
